Background/Aims It remains uncertain which patients with stricturing-type Crohn’s disease (CD) require early small bowel surgery after the initial diagnosis. We aimed to clarify clinical characteristics associated with the intervention in such condition of CD.
Methods We retrospectively evaluated the clinical course of 53 patients with CD and small bowel strictures who were initially treated with medications after the initial diagnosis. We investigated possible associations between small bowel surgery and the following: clinical factors and radiologic findings at initial diagnosis and the types of medications administered during follow-up.
Results Twenty-eight patients (53%) required small bowel resection during a median follow-up period of 5.0 years (range, 0.5–14.3 years). The cumulative incidence rates of small bowel surgery at 2, 5, and 10 years were 26.4%, 41.0%, and 63.2%, respectively. Univariate analysis indicated that obstructive symptoms (P=0.036), long-segment stricture (P<0.0001), and prestenotic dilation (P<0.0001) on radiography were associated with small bowel surgery, and immunomodulatory (P=0.037) and biological therapy (P=0.008) were significant factors during follow-up. Multivariate analysis revealed that long-segment stricture (hazard ratio [HR], 4.25; 95% confidence interval [CI], 1.78–10.53; P=0.001) and prestenotic dilation (HR, 3.41; 95% CI, 1.24–9.62; P=0.018) on radiography showed a positive correlation with small bowel surgery, and biological therapy (HR, 0.40; 95% CI, 0.15–0.99; P=0.048) showed a negative correlation.
Conclusions CD patients with long-segment stricture and prestenotic dilation on radiography seem to be at a higher risk of needing small bowel surgery. For such patients, early surgical intervention might be appropriate, even at initial diagnosis.
Citations
Citations to this article as recorded by
Risk factors for stricture-related surgery in stricturing Crohn’s disease Emil Yunusov, Betul Piyade, Ilkay Ergenc, Muhammed Enes Tasci, Nisanur Sariyar, Yesim Ozen Alahdab, Ozlen Atug, Haluk Tarik Kani BMC Gastroenterology.2026;[Epub] CrossRef
Colonic strictures in Crohn’s disease: a non-surgical survival Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker Future Science OA.2025;[Epub] CrossRef
Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers Safa Hoodeshenas, Jonathan R. Dillman, Stuart A. Taylor, Jordi Rimola, Bachir Taouli, Kathryn A. Robinson, Aiming Lu, David J. Bartlett, David H. Bruining, Catherine E. Hagen, Ajit H. Goenka, Shigao Chen, Florian Rieder, Brian Feagan, Mark E. Baker, Joel RadioGraphics.2025;[Epub] CrossRef
Comprehensive review and update of stricturing Crohn’s disease Alexander T. Elford, Zaid Ardalan, Paul Simkin, Britt Christensen Indian Journal of Gastroenterology.2024; 43(1): 64. CrossRef
A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice Dominik Bettenworth, Mark E. Baker, Joel G. Fletcher, Vipul Jairath, Cathy Lu, Willem Bemelman, Geert d’Haens, Andre d’Hoore, Axel Dignass, Iris Dotan, Roger Feakins, Phillip Fleshner, Christina Ha, Gaylyn Henderson, Ruishen Lyu, Julian Panes, Gerhard Rog Nature Reviews Gastroenterology & Hepatology.2024; 21(8): 572. CrossRef
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease Florian Rieder, Mark E. Baker, David H. Bruining, Jeff L. Fidler, Eric C. Ehman, Shannon P. Sheedy, Jay P. Heiken, Justin M. Ream, David R. Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S. Lee, Stuart A. Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wa Radiology.2024;[Epub] CrossRef
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease Florian Rieder, Christopher Ma, Jurij Hanzel, Joel G. Fletcher, Mark E. Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M. Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S. Santillan, Nunzia Capozzi, Stuart A. Taylor, David Radiology.2024;[Epub] CrossRef
Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai Nutrition in Clinical Practice.2023; 38(6): 1282. CrossRef
Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: Preliminary results Asuka Yasueda, Yuki Sekido, Takashi Takeda, Takayuki Ogino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Yuichiro Doki, Hidetoshi Eguchi, Tsunekazu Mizushima Nutrition.2022; 94: 111526. CrossRef
Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton, Alyson L Ross, Michael A Kamm Journal of Gastroenterology and Hepatology.2021; 36(2): 344. CrossRef
Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon Gut and Liver.2021; 15(1): 92. CrossRef
Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease Muaad Abdulla, Thean Soon Chew Current Opinion in Gastroenterology.2021; 37(3): 275. CrossRef
Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease Sudheer K. Vuyyuru, Bhaskar Kante, Peeyush Kumar, Pabitra Sahu, Saurabh Kedia, Mukesh Kumar Ranjan, Raju Sharma, Rajesh Panwar, Govind Makharia, Vineet Ahuja Scientific Reports.2021;[Epub] CrossRef
Inpatient Management of Inflammatory Bowel Disease-Related Complications Manreet Kaur, Robin L. Dalal, Seth Shaffer, David A. Schwartz, David T. Rubin Clinical Gastroenterology and Hepatology.2020; 18(6): 1346. CrossRef
Surgical treatment of intestinal stricture in inflammatory bowel disease Helen M. Mohan, John C. Coffey Journal of Digestive Diseases.2020; 21(6): 355. CrossRef